What is the dosage of simethicone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Simethicone Dosage Recommendations

For adults, the recommended dosage of simethicone is 180 mg, taken 1-2 softgels as needed after meals and at bedtime, not exceeding 2 softgels in 24 hours unless directed by a physician. 1

Standard Adult Dosing

  • The FDA-approved dosage for simethicone in adults is 180 mg per softgel, with instructions to take 1-2 softgels as needed after meals and at bedtime 1
  • Maximum daily dose should not exceed 2 softgels (360 mg total) in 24 hours without physician supervision 1
  • Simethicone should be swallowed with water for optimal effectiveness 1

Simethicone for Colonoscopy Preparation

  • When used as an adjunct for bowel preparation before colonoscopy, the US Multi-Society Task Force on Colorectal Cancer recommends a dose of at least 320 mg 2
  • Higher doses (320 mg or more) have been associated with improved bowel preparation quality and fewer bubbles during colonoscopy 2
  • Various clinical trials have used different doses ranging from 200 mg to 1,200 mg:
    • 400 mg added to the final 500 mL of consumed clear liquid during a 2L PEG + ascorbate regimen significantly improved bowel preparation quality 2
    • 1,200 mg added to a single-dose 2L PEG regimen also significantly improved bowel preparation quality 2

Timing of Administration

  • For general use, simethicone is typically taken after meals and at bedtime 1
  • For colonoscopy preparation, the timing of simethicone administration shows variable results:
    • One study found no difference in bowel preparation scores whether simethicone was taken with the first or second dose of split-dose bowel prep 2
    • Earlier dosing of simethicone (200 mg) was associated with shorter cecal intubation times and higher detection of diminutive right-sided adenomas 2
    • Some studies show fewer bubbles with evening dosing, while others show better results with morning dosing on the day of colonoscopy 2

Clinical Benefits and Considerations

  • Simethicone significantly reduces abdominal bloating compared to placebo when used as an adjunct to bowel preparation 3
  • The addition of simethicone to PEG-based bowel preparation reduces the need for intraprocedural simethicone from 49% to 2% of colonoscopies 2
  • When combined with loperamide (125 mg simethicone), it provides faster relief of acute diarrhea and associated gas-related abdominal discomfort than either component alone 4
  • For endoscopic procedures, simethicone combined with N-acetylcysteine improves mucosal visibility during upper GI endoscopy 5

Special Considerations

  • For endoscopic procedures, the American Society for Gastrointestinal Endoscopy recommends using the lowest concentration (0.5% v/v; 10 mg/100 mL) and smallest volume of simethicone if administered through the endoscope 2
  • When adding simethicone to a bowel preparation regimen, consider the out-of-pocket cost to the patient 2
  • No significant differences in adverse events have been reported between simethicone and placebo in clinical trials 4, 3

Common Pitfalls and Caveats

  • Exceeding the recommended maximum daily dose (360 mg for general use) without medical supervision should be avoided 1
  • For colonoscopy preparation, higher doses (320 mg or more) may be used under medical supervision 2
  • While simethicone improves bowel preparation quality and reduces bubbles, it has not consistently shown improvement in adenoma detection rates in all studies 2
  • Standard reprocessing protocols may not effectively remove simethicone from endoscope channels, so using the lowest effective concentration is recommended when administered through an endoscope 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.